Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · IEX Real-Time Price · USD

3.020

-0.040 (-1.31%)

At close: Apr 25, 2024, 4:00 PM

3.059

+0.039 (1.29%)

Pre-market: Apr 26, 2024, 8:08 AM EDT

Cellectar Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Selling, General & Admin	10.75	9.59	6.54	5.15	5.18	4.82	4.14	4.7	3.4	3.7	Upgrade
Research & Development	28.21	19.22	17.59	10.14	9	6.84	9.47	4.75	5.16	5.96	Upgrade
Other Operating Expenses	0	0	0	0	0	1.68	0	0	0.2	0.22	Upgrade
Operating Expenses	38.96	28.81	24.13	15.29	14.18	13.33	13.6	9.45	8.76	9.89	Upgrade
Operating Income	-38.96	-28.81	-24.13	-15.29	-14.18	-13.33	-13.6	-9.45	-8.76	-9.89	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.01	-0	0.45	Upgrade
Other Expense / Income	-0.92	-0.15	-0.01	-0.2	-0.09	-0.09	-0.04	-3.28	-3.26	-2.29	Upgrade
Pretax Income	-38.04	-28.66	-24.12	-15.09	-14.09	-13.24	-13.56	-6.18	-5.5	-8.05	Upgrade
Income Tax	-0.06	-0.06	0	0	0	0	0	0	0	0	Upgrade
Net Income	-37.98	-28.6	-24.12	-15.09	-14.09	-13.24	-13.56	-6.18	-5.5	-8.05	Upgrade
Preferred Dividends	0	0	0	0	0	2.24	1.45	3.18	0	0	Upgrade
Net Income Common	-37.98	-28.6	-24.12	-15.09	-14.09	-15.48	-15.01	-9.36	-5.5	-8.05	Upgrade
Shares Outstanding (Basic)	12	7	6	2	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	12	7	6	2	1	0	0	0	0	0	Upgrade
Shares Change	73.22%	27.09%	180.20%	158.14%	159.12%	111.10%	221.33%	458.39%	70.26%	64.33%	Upgrade
EPS (Basic)	-3.11	-4.05	-4.35	-7.60	-18.40	-52.30	-107.00	-214.00	-703.00	-1753.00	Upgrade
EPS (Diluted)	-3.11	-4.05	-4.35	-7.60	-18.40	-52.30	-107.00	-214.00	-703.00	-1753.00	Upgrade
Free Cash Flow	-33.24	-25.45	-22.71	-14	-11.72	-11.77	-11.37	-8.35	-8.27	-8.87	Upgrade
Free Cash Flow Per Share	-2.72	-3.61	-4.09	-7.06	-15.27	-39.74	-81.01	-191.33	-1057.76	-1931.35	Upgrade
EBITDA	-37.79	-28.42	-23.89	-14.89	-13.9	-13.16	-12.02	-5.82	-5.13	-7.24	Upgrade
Depreciation & Amortization	0.25	0.24	0.23	0.21	0.19	0.08	1.55	0.36	0.36	0.37	Upgrade
EBIT	-38.04	-28.66	-24.12	-15.09	-14.09	-13.24	-13.56	-6.17	-5.5	-7.61	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).